In May, the Trump administration ended federal funding for the Center for HIV/AIDS Vaccine Development. The successful program produced clinical trials for three different vaccine candidates. While other funding sources are possible for continued study, the National Institute of Allergy and Infectious Diseases is responsible for around 80% of HIV vaccine research globally.

This cancellation was not a one-time event: Since the Trump administration has assumed power, it has cancelled nearly $800 million in research grants given by the National Institutes of Health. In addition, the White House’s proposed budget for the 2026 fiscal year includes vast reductions in NIH funding, among other health agencies. This includes several grants to the University of Michigan, as well as cuts to

See Full Page